TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global NSCLC Drugs Market Insights, Forecast to 2028

Global NSCLC Drugs Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 25 August 2022
  • Pages :106
  • Formats:
  • Report Code:SMR-7293827
OfferClick for best price

Best Price: $3920

NSCLC Drugs Market Size, Share 2022


Market Analysis and Insights: Global NSCLC Drugs Market

The global NSCLC Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NSCLC Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NSCLC Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NSCLC Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NSCLC Drugs market.

Global NSCLC Drugs Scope and Market Size

NSCLC Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global NSCLC Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Oral Type

Injection Type

Segment by Application

Squamous Cell Lung Carcinoma

Large-cell Lung Carcinoma

By Company

Merck

Bristol-Myers Squibb

Regeneron Pharmaceuticals

Novartis

Jiangsu Hengrui Medicine

Innovent Biologics

Shanghai Junshi Biosciences

BeiGene

Roche

AstraZeneca

Pfizer

Boehringer-Ingelheim

Teva

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes NSCLC Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of NSCLC Drugs, with price, sales, revenue, and global market share of NSCLC Drugs from 2019 to 2022.

Chapter 3, the NSCLC Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the NSCLC Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the NSCLC Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of NSCLC Drugs.

Chapter 13, 14, and 15, to describe NSCLC Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 NSCLC Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global NSCLC Drugs Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 106 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NSCLC Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Type
1.2.3 Injection Type
1.3 Market by Application
1.3.1 Global NSCLC Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Squamous Cell Lung Carcinoma
1.3.3 Large-cell Lung Carcinoma
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global NSCLC Drugs Market Perspective (2017-2028)
2.2 NSCLC Drugs Growth Trends by Region
2.2.1 NSCLC Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 NSCLC Drugs Historic Market Size by Region (2017-2022)
2.2.3 NSCLC Drugs Forecasted Market Size by Region (2023-2028)
2.3 NSCLC Drugs Market Dynamics
2.3.1 NSCLC Drugs Industry Trends
2.3.2 NSCLC Drugs Market Drivers
2.3.3 NSCLC Drugs Market Challenges
2.3.4 NSCLC Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NSCLC Drugs Players by Revenue
3.1.1 Global Top NSCLC Drugs Players by Revenue (2017-2022)
3.1.2 Global NSCLC Drugs Revenue Market Share by Players (2017-2022)
3.2 Global NSCLC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NSCLC Drugs Revenue
3.4 Global NSCLC Drugs Market Concentration Ratio
3.4.1 Global NSCLC Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NSCLC Drugs Revenue in 2021
3.5 NSCLC Drugs Key Players Head office and Area Served
3.6 Key Players NSCLC Drugs Product Solution and Service
3.7 Date of Enter into NSCLC Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NSCLC Drugs Breakdown Data by Type
4.1 Global NSCLC Drugs Historic Market Size by Type (2017-2022)
4.2 Global NSCLC Drugs Forecasted Market Size by Type (2023-2028)
5 NSCLC Drugs Breakdown Data by Application
5.1 Global NSCLC Drugs Historic Market Size by Application (2017-2022)
5.2 Global NSCLC Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America NSCLC Drugs Market Size (2017-2028)
6.2 North America NSCLC Drugs Market Size by Type
6.2.1 North America NSCLC Drugs Market Size by Type (2017-2022)
6.2.2 North America NSCLC Drugs Market Size by Type (2023-2028)
6.2.3 North America NSCLC Drugs Market Share by Type (2017-2028)
6.3 North America NSCLC Drugs Market Size by Application
6.3.1 North America NSCLC Drugs Market Size by Application (2017-2022)
6.3.2 North America NSCLC Drugs Market Size by Application (2023-2028)
6.3.3 North America NSCLC Drugs Market Share by Application (2017-2028)
6.4 North America NSCLC Drugs Market Size by Country
6.4.1 North America NSCLC Drugs Market Size by Country (2017-2022)
6.4.2 North America NSCLC Drugs Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe NSCLC Drugs Market Size (2017-2028)
7.2 Europe NSCLC Drugs Market Size by Type
7.2.1 Europe NSCLC Drugs Market Size by Type (2017-2022)
7.2.2 Europe NSCLC Drugs Market Size by Type (2023-2028)
7.2.3 Europe NSCLC Drugs Market Share by Type (2017-2028)
7.3 Europe NSCLC Drugs Market Size by Application
7.3.1 Europe NSCLC Drugs Market Size by Application (2017-2022)
7.3.2 Europe NSCLC Drugs Market Size by Application (2023-2028)
7.3.3 Europe NSCLC Drugs Market Share by Application (2017-2028)
7.4 Europe NSCLC Drugs Market Size by Country
7.4.1 Europe NSCLC Drugs Market Size by Country (2017-2022)
7.4.2 Europe NSCLC Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NSCLC Drugs Market Size (2017-2028)
8.2 Asia-Pacific NSCLC Drugs Market Size by Type
8.2.1 Asia-Pacific NSCLC Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific NSCLC Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific NSCLC Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific NSCLC Drugs Market Size by Application
8.3.1 Asia-Pacific NSCLC Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific NSCLC Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific NSCLC Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific NSCLC Drugs Market Size by Region
8.4.1 Asia-Pacific NSCLC Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific NSCLC Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America NSCLC Drugs Market Size (2017-2028)
9.2 Latin America NSCLC Drugs Market Size by Type
9.2.1 Latin America NSCLC Drugs Market Size by Type (2017-2022)
9.2.2 Latin America NSCLC Drugs Market Size by Type (2023-2028)
9.2.3 Latin America NSCLC Drugs Market Share by Type (2017-2028)
9.3 Latin America NSCLC Drugs Market Size by Application
9.3.1 Latin America NSCLC Drugs Market Size by Application (2017-2022)
9.3.2 Latin America NSCLC Drugs Market Size by Application (2023-2028)
9.3.3 Latin America NSCLC Drugs Market Share by Application (2017-2028)
9.4 Latin America NSCLC Drugs Market Size by Country
9.4.1 Latin America NSCLC Drugs Market Size by Country (2017-2022)
9.4.2 Latin America NSCLC Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NSCLC Drugs Market Size (2017-2028)
10.2 Middle East & Africa NSCLC Drugs Market Size by Type
10.2.1 Middle East & Africa NSCLC Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa NSCLC Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa NSCLC Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa NSCLC Drugs Market Size by Application
10.3.1 Middle East & Africa NSCLC Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa NSCLC Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa NSCLC Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa NSCLC Drugs Market Size by Country
10.4.1 Middle East & Africa NSCLC Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa NSCLC Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck NSCLC Drugs Introduction
11.1.4 Merck Revenue in NSCLC Drugs Business (2017-2022)
11.1.5 Merck Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb NSCLC Drugs Introduction
11.2.4 Bristol-Myers Squibb Revenue in NSCLC Drugs Business (2017-2022)
11.2.5 Bristol-Myers Squibb Recent Developments
11.3 Regeneron Pharmaceuticals
11.3.1 Regeneron Pharmaceuticals Company Details
11.3.2 Regeneron Pharmaceuticals Business Overview
11.3.3 Regeneron Pharmaceuticals NSCLC Drugs Introduction
11.3.4 Regeneron Pharmaceuticals Revenue in NSCLC Drugs Business (2017-2022)
11.3.5 Regeneron Pharmaceuticals Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis NSCLC Drugs Introduction
11.4.4 Novartis Revenue in NSCLC Drugs Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 Jiangsu Hengrui Medicine
11.5.1 Jiangsu Hengrui Medicine Company Details
11.5.2 Jiangsu Hengrui Medicine Business Overview
11.5.3 Jiangsu Hengrui Medicine NSCLC Drugs Introduction
11.5.4 Jiangsu Hengrui Medicine Revenue in NSCLC Drugs Business (2017-2022)
11.5.5 Jiangsu Hengrui Medicine Recent Developments
11.6 Innovent Biologics
11.6.1 Innovent Biologics Company Details
11.6.2 Innovent Biologics Business Overview
11.6.3 Innovent Biologics NSCLC Drugs Introduction
11.6.4 Innovent Biologics Revenue in NSCLC Drugs Business (2017-2022)
11.6.5 Innovent Biologics Recent Developments
11.7 Shanghai Junshi Biosciences
11.7.1 Shanghai Junshi Biosciences Company Details
11.7.2 Shanghai Junshi Biosciences Business Overview
11.7.3 Shanghai Junshi Biosciences NSCLC Drugs Introduction
11.7.4 Shanghai Junshi Biosciences Revenue in NSCLC Drugs Business (2017-2022)
11.7.5 Shanghai Junshi Biosciences Recent Developments
11.8 BeiGene
11.8.1 BeiGene Company Details
11.8.2 BeiGene Business Overview
11.8.3 BeiGene NSCLC Drugs Introduction
11.8.4 BeiGene Revenue in NSCLC Drugs Business (2017-2022)
11.8.5 BeiGene Recent Developments
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche NSCLC Drugs Introduction
11.9.4 Roche Revenue in NSCLC Drugs Business (2017-2022)
11.9.5 Roche Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca NSCLC Drugs Introduction
11.10.4 AstraZeneca Revenue in NSCLC Drugs Business (2017-2022)
11.10.5 AstraZeneca Recent Developments
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer NSCLC Drugs Introduction
11.11.4 Pfizer Revenue in NSCLC Drugs Business (2017-2022)
11.11.5 Pfizer Recent Developments
11.12 Boehringer-Ingelheim
11.12.1 Boehringer-Ingelheim Company Details
11.12.2 Boehringer-Ingelheim Business Overview
11.12.3 Boehringer-Ingelheim NSCLC Drugs Introduction
11.12.4 Boehringer-Ingelheim Revenue in NSCLC Drugs Business (2017-2022)
11.12.5 Boehringer-Ingelheim Recent Developments
11.13 Teva
11.13.1 Teva Company Details
11.13.2 Teva Business Overview
11.13.3 Teva NSCLC Drugs Introduction
11.13.4 Teva Revenue in NSCLC Drugs Business (2017-2022)
11.13.5 Teva Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global NSCLC Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Oral Type
Table 3. Key Players of Injection Type
Table 4. Global NSCLC Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global NSCLC Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global NSCLC Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global NSCLC Drugs Market Share by Region (2017-2022)
Table 8. Global NSCLC Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global NSCLC Drugs Market Share by Region (2023-2028)
Table 10. NSCLC Drugs Market Trends
Table 11. NSCLC Drugs Market Drivers
Table 12. NSCLC Drugs Market Challenges
Table 13. NSCLC Drugs Market Restraints
Table 14. Global NSCLC Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global NSCLC Drugs Revenue Share by Players (2017-2022)
Table 16. Global Top NSCLC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSCLC Drugs as of 2021)
Table 17. Ranking of Global Top NSCLC Drugs Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by NSCLC Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players NSCLC Drugs Product Solution and Service
Table 21. Date of Enter into NSCLC Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NSCLC Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global NSCLC Drugs Revenue Market Share by Type (2017-2022)
Table 25. Global NSCLC Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global NSCLC Drugs Revenue Market Share by Type (2023-2028)
Table 27. Global NSCLC Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global NSCLC Drugs Revenue Share by Application (2017-2022)
Table 29. Global NSCLC Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global NSCLC Drugs Revenue Share by Application (2023-2028)
Table 31. North America NSCLC Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America NSCLC Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America NSCLC Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America NSCLC Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America NSCLC Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America NSCLC Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe NSCLC Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe NSCLC Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe NSCLC Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe NSCLC Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe NSCLC Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe NSCLC Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific NSCLC Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific NSCLC Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific NSCLC Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific NSCLC Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific NSCLC Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific NSCLC Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America NSCLC Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America NSCLC Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America NSCLC Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America NSCLC Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America NSCLC Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America NSCLC Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa NSCLC Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa NSCLC Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa NSCLC Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa NSCLC Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa NSCLC Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa NSCLC Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck NSCLC Drugs Product
Table 64. Merck Revenue in NSCLC Drugs Business (2017-2022) & (US$ Million)
Table 65. Merck Recent Developments
Table 66. Bristol-Myers Squibb Company Details
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb NSCLC Drugs Product
Table 69. Bristol-Myers Squibb Revenue in NSCLC Drugs Business (2017-2022) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Developments
Table 71. Regeneron Pharmaceuticals Company Details
Table 72. Regeneron Pharmaceuticals Business Overview
Table 73. Regeneron Pharmaceuticals NSCLC Drugs Product
Table 74. Regeneron Pharmaceuticals Revenue in NSCLC Drugs Business (2017-2022) & (US$ Million)
Table 75. Regeneron Pharmaceuticals Recent Developments
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis NSCLC Drugs Product
Table 79. Novartis Revenue in NSCLC Drugs Business (2017-2022) & (US$ Million)
Table 80. Novartis Recent Developments
Table 81. Jiangsu Hengrui Medicine Company Details
Table 82. Jiangsu Hengrui Medicine Business Overview
Table 83. Jiangsu Hengrui Medicine NSCLC Drugs Product
Table 84. Jiangsu Hengrui Medicine Revenue in NSCLC Drugs Business (2017-2022) & (US$ Million)
Table 85. Jiangsu Hengrui Medicine Recent Developments
Table 86. Innovent Biologics Company Details
Table 87. Innovent Biologics Business Overview
Table 88. Innovent Biologics NSCLC Drugs Product
Table 89. Innovent Biologics Revenue in NSCLC Drugs Business (2017-2022) & (US$ Million)
Table 90. Innovent Biologics Recent Developments
Table 91. Shanghai Junshi Biosciences Company Details
Table 92. Shanghai Junshi Biosciences Business Overview
Table 93. Shanghai Junshi Biosciences NSCLC Drugs Product
Table 94. Shanghai Junshi Biosciences Revenue in NSCLC Drugs Business (2017-2022) & (US$ Million)
Table 95. Shanghai Junshi Biosciences Recent Developments
Table 96. BeiGene Company Details
Table 97. BeiGene Business Overview
Table 98. BeiGene NSCLC Drugs Product
Table 99. BeiGene Revenue in NSCLC Drugs Business (2017-2022) & (US$ Million)
Table 100. BeiGene Recent Developments
Table 101. Roche Company Details
Table 102. Roche Business Overview
Table 103. Roche NSCLC Drugs Product
Table 104. Roche Revenue in NSCLC Drugs Business (2017-2022) & (US$ Million)
Table 105. Roche Recent Developments
Table 106. AstraZeneca Company Details
Table 107. AstraZeneca Business Overview
Table 108. AstraZeneca NSCLC Drugs Product
Table 109. AstraZeneca Revenue in NSCLC Drugs Business (2017-2022) & (US$ Million)
Table 110. AstraZeneca Recent Developments
Table 111. Pfizer Company Details
Table 112. Pfizer Business Overview
Table 113. Pfizer NSCLC Drugs Product
Table 114. Pfizer Revenue in NSCLC Drugs Business (2017-2022) & (US$ Million)
Table 115. Pfizer Recent Developments
Table 116. Boehringer-Ingelheim Company Details
Table 117. Boehringer-Ingelheim Business Overview
Table 118. Boehringer-Ingelheim NSCLC Drugs Product
Table 119. Boehringer-Ingelheim Revenue in NSCLC Drugs Business (2017-2022) & (US$ Million)
Table 120. Boehringer-Ingelheim Recent Developments
Table 121. Teva Company Details
Table 122. Teva Business Overview
Table 123. Teva NSCLC Drugs Product
Table 124. Teva Revenue in NSCLC Drugs Business (2017-2022) & (US$ Million)
Table 125. Teva Recent Developments
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NSCLC Drugs Market Share by Type: 2021 VS 2028
Figure 2. Oral Type Features
Figure 3. Injection Type Features
Figure 4. Global NSCLC Drugs Market Share by Application: 2021 VS 2028
Figure 5. Squamous Cell Lung Carcinoma Case Studies
Figure 6. Large-cell Lung Carcinoma Case Studies
Figure 7. NSCLC Drugs Report Years Considered
Figure 8. Global NSCLC Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global NSCLC Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global NSCLC Drugs Market Share by Region: 2021 VS 2028
Figure 11. Global NSCLC Drugs Market Share by Players in 2021
Figure 12. Global Top NSCLC Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSCLC Drugs as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by NSCLC Drugs Revenue in 2021
Figure 14. North America NSCLC Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America NSCLC Drugs Market Size Market Share by Type (2017-2028)
Figure 16. North America NSCLC Drugs Market Size Market Share by Application (2017-2028)
Figure 17. North America NSCLC Drugs Market Size Share by Country (2017-2028)
Figure 18. United States NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe NSCLC Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe NSCLC Drugs Market Size Market Share by Type (2017-2028)
Figure 22. Europe NSCLC Drugs Market Size Market Share by Application (2017-2028)
Figure 23. Europe NSCLC Drugs Market Size Share by Country (2017-2028)
Figure 24. Germany NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific NSCLC Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific NSCLC Drugs Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific NSCLC Drugs Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific NSCLC Drugs Market Size Share by Region (2017-2028)
Figure 34. China NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 40. Latin America NSCLC Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America NSCLC Drugs Market Size Market Share by Type (2017-2028)
Figure 42. Latin America NSCLC Drugs Market Size Market Share by Application (2017-2028)
Figure 43. Latin America NSCLC Drugs Market Size Share by Country (2017-2028)
Figure 44. Mexico NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa NSCLC Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa NSCLC Drugs Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa NSCLC Drugs Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa NSCLC Drugs Market Size Share by Country (2017-2028)
Figure 50. Turkey NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE NSCLC Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Merck Revenue Growth Rate in NSCLC Drugs Business (2017-2022)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in NSCLC Drugs Business (2017-2022)
Figure 55. Regeneron Pharmaceuticals Revenue Growth Rate in NSCLC Drugs Business (2017-2022)
Figure 56. Novartis Revenue Growth Rate in NSCLC Drugs Business (2017-2022)
Figure 57. Jiangsu Hengrui Medicine Revenue Growth Rate in NSCLC Drugs Business (2017-2022)
Figure 58. Innovent Biologics Revenue Growth Rate in NSCLC Drugs Business (2017-2022)
Figure 59. Shanghai Junshi Biosciences Revenue Growth Rate in NSCLC Drugs Business (2017-2022)
Figure 60. BeiGene Revenue Growth Rate in NSCLC Drugs Business (2017-2022)
Figure 61. Roche Revenue Growth Rate in NSCLC Drugs Business (2017-2022)
Figure 62. AstraZeneca Revenue Growth Rate in NSCLC Drugs Business (2017-2022)
Figure 63. Pfizer Revenue Growth Rate in NSCLC Drugs Business (2017-2022)
Figure 64. Boehringer-Ingelheim Revenue Growth Rate in NSCLC Drugs Business (2017-2022)
Figure 65. Teva Revenue Growth Rate in NSCLC Drugs Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount